7:00 AM —
7:00 PM

Exhibits Open

7:00 AM —
7:45 AM

Continental Breakfast Provided

7:45 AM —
9:00 AM

Welcome & General Session I: Controversial Topics in Medical Oncology Management

Chair: Lori Goldstein, MD – Fox Chase Cancer Center

• Role of mTOR Inhibitors in Metastatic Disease
  William John Gradishar, MD – Northwestern University

• Role of Chemotherapy for Small TN and HER2+ Cancers
  Robert Carlson, MD – Stanford Comprehensive Cancer Center

9:00 AM —
9:30 AM

Break

9:30 AM — 11:00 AM

General Session II: Risk Assessment, Prevention, Detection, and Screening

Chair: Banu Arun, MD – M. D. Anderson Cancer Center

• What is High Risk, What is the Definition of Genetic Testing and What To Do With the Results
  Claudine Isaacs, MD – Georgeotwn University

• Imaging Techniques: What Works, What Doesn’t
  David A. Mankoff, MD, PhD - University of Washington                                         

• The Value of Risk-Reducing Surgery for Premalignant Lesions, DCIS, ADH
  Todd M. Tuttle, MD, MS – University of Minnesota

• Medical Management/Prevention of Premalignant Lesions DCIS, LCIS, ADH
  Victor Vogel, MD, MHS – Geisinger Health System

11:00 AM — 1:00 PM

General Poster Session A

(with complimentary boxed lunch)

11:10 AM — 11:40 AM

Poster Walks

(four groups) 

Seema Khan, MD – Northwestern University
Meena S. Moran, MD - Yale University School of Medicine
Lori Pierce, MD – University of Michigan
Shawna Willey, MD – Georgetown University
 

11:45 AM — 12:45 PM

Tumor Board

Panelists:
Lori J. Pierce, MD – University of Michigan
Shawna Willey, MD – Georgetown University
Daniel Hayes, MD – University of Michigan
Anna Maria Storniolo, MD – IU Simon Cancer Center
Kathryn Evers, MD - Fox Chase Cancer Center
 

1:00 PM —
2:15 PM

General Session III: Controversies in Diagnosis of Early Stage Breast Cancer and Management of Sentinel Nodes

Chairs: Jennifer Bellon, MD – Dana-Farber Cancer Institute; Richard Bleicher, MD – Fox Chase Cancer Center

• MRI Debate 
  Moderator: Richard Bleicher, MD – Fox Chase Cancer Center
  Pro: Constance D. Lehman, MD, PhD, FACR – Seattle Cancer Care Alliance
  Con: Kathryn Evers, MD – Fox Chase Cancer Center

• Panel Discussion: Reconciling the Z0011 Approach to Nodal Management of Sentinel Node Positive Disease with MA.20
  Case Presentations: Jennifer Bellon, MD – Dana-Farber Cancer Institute
  Surgeon: Monica Morrow – MD – Memorial Sloan-Kettering Cancer Center
  Surgeon: Michael S. Sabel, MD – University of Michigan
  Radiation Oncologist: Reshma Jagsi, MD – University of Michigan
  Radiation Oncologist: Alice Ho, MD - Memorial Sloan-Kettering Cancer Center

2:15 PM —
2:45 PM

Break

2:45 PM —
4:00 PM

General Session IV: Controversies in Local/Regional Treatment

Chairs: Lori Pierce, MD – University of Michigan; Robert Kuske, MD – Arizona Breast Cancer Specialists

• Intraoperative Radiation Therapy: Analysis of a Randomized Trial
  Jayant Vaidya, PhD – University College London

• Intraoperative Radiation Therapy: A Practical Perspective
  Julia White, MD - The Stefanie Spielman Comprehensive Breast Center

• Debate on Role of Local Radiation Therapy in DCIS
  Moderator: Robert Kuske, MD – Arizona Breast Cancer Specialists
  Pro: Thomas B. Julian, MD – Drexel University College of Medicine
  Con: Abram Recht, MD - Beth Israel Deaconess Medical Center

4:00 PM —
4:30 PM

4:30 PM —
5:30 PM

Poster Discussion: Risk Assessment, Prevention, Detection, and Screening
 

5:30 PM —
7:00 PM

General Poster Session B: Local/Regional Therapy

(with complimentary wine and cheese reception)

7:00 AM —
7:00 PM

Exhibits Open

7:00 AM —
8:00 AM

Continental Breakfast Provided

7:00 AM —
8:00 AM

Meet the Professor Sessions

(Three concurrent sessions)

• Management of the Clinically Negative Axilla
  Monica Morrow, MD – Memorial Sloan-Kettering Cancer Center

• Reassessing Local Treatment in the Context of Increasingly Effective Systemic Therapy
  Jay R. Harris, MD – Dana-Farber Cancer Institute

• Marker-driven Personalized Therapy of Breast Cancer
  Gabriel N. Hortobagyi, MD – M. D. Anderson Cancer Center

Welcome and General Session V: Genomics for the Clinician

Chair: Mark D. Pegram, MD - Stanford University

• New Horizons in Breast Cancer ‘Omics
  Matthew J. Ellis, MD – Washington University

• Future Directions in Genomics for Metastatic Disease
  Charles E. Geyer, Jr., MD – CTNeT

• Role of Genomic Testing in Node Positive Patients
  Anna Maria Gonzalez, MD – M. D. Anderson

9:15 AM —
9:45 AM

Break

9:45 AM — 10:30 AM

ASCO Gianni Bonnadonna Breast Cancer Award and Lecture

2012 Awardee is Monica Morrow, MD - Memorial Sloan-Kettering Cancer Center
 

10:30 AM — 11:15 AM

General Session VI: Healthcare Delivery and Prevention

Chair: Bruce Haffty, MD - The Cancer Institute of New Jersey

• Breast Healthcare Delivery in Context: The World Health Organization's Initiative for Non-communicable Diseases
  Benjamin O. Anderson, MD - Fred Hutchinson Cancer Research Center
   
• Reducing Breast Cancer Risk: Progress Towards Resolution
  Rowan T. Chlebowski, MD, PhD - David Geffen School of Medicine at UCLA

11:15 AM — 1:15 PM

General Poster Session C: Survivorship and Health Policy

(with complimentary boxed lunch provided)

11:30 AM — 1:00 PM

Poster Walks 

(Six groups)

11:30 AM - 12:00 PM
Lori Goldstein, MD – Fox Chase Cancer Center
Sandhya Pruthi, MD – Mayo Clinic

12:00 PM - 12:30 PM
Hope S. Rugo, MD – UCSF Helen Diller Family Comprehensive Cancer Center
William Sikov, MD – Brown University

12:30 PM - 1:00 PM
Kathy S. Albain, MD - Loyola University
Melinda Telli, MD – Stanford University
 

1:15 PM —
2:45 PM

General session VII: Survivorship

Chair: Kathy S. Albain, MD - Loyola University; Sandra M. Swain, MD – Washington Cancer Institute

• Transition from Active Treatment to “Normal Life” as a Survivor
  Denise O'Neill - Holy Cross Hospital   

• Obesity in Survivorship
  Patrick Morris, MD – Memorial Sloan-Kettering Cancer Center

• Managing Menopausal Symptoms in Breast Cancer Patients
  Patrick Neven, MD – Leuven Cancer Institute

• Quality Measures in Survivorship
  Ann H. Patridge, MD, PhD – Dana-Farber Cancer Institute

2:45 PM —
3:15 PM

Break

3:15 PM —
4:30 PM

General Session VIII: The Future of Health Policy

Chair: Richard L. White, Jr., MD – Blumenthal Cancer Center

• Reducing Disparities
  Claudia R. Baquet, MD, MPH – University of Maryland School of Medicine

• What are the Differences Between Using a New Drug and a New Technology
  Gary H. Lyman, MD, MPH - Duke University School of Medicine

• Rapid Learning Systems
  Sandra M. Swain, MD – Washington Cancer Institute

4:30 PM —
4:45 PM

Break

4:45 PM —
5:45 PM

Poster Discussion B: Survivorship and Health Policy
 

5:45 PM —
7:00 PM

 General Poster Session D: Systemic Therapy

(with complimentary wine and cheese reception)
 

7:00 AM —
8:00 AM

Fellows, Residents, and junior faculty networking breakfast

Chairs: Hope S. Rugo, MD – UCSF Helen Diller Family Comprehensive Cancer Center; Meena S. Moran, MD - Yale University School of Medicine
 

7:00 AM —
8:00 AM

Continental Breakfast Provided

8:00 AM —
9:30 AM

welcome and General Session IX: New directions in systemic therapy for advanced Disease

Chairs: Eric P. Winer, MD – Dana-Farber Cancer Institute; Heather McArthur, MD. MPH – Memorial Sloan-Kettering Cancer Center

• An Update on HER2 Positive Breast Cancer
  Mark D. Pegram, MD - Stanford University                                                        

• Hormone Responsive Disease
  Francisco J. Esteva, MD, PhD – M. D. Anderson Cancer Center

• Treatment strategies for Triple Negative Patients
  Lisa A. Carey, MD – Lineberger Comprehensive Cancer Center
  
   
• Panel Discussion
  Moderator: Eric P. Winer, MD - Dana-Farber Cancer Institute

9:30 AM —
9:50 AM

Break

9:50 AM — 10:40 AM

General Session X: Health Policy: opportunities and Challenges

Chair: Richard L. White, Jr., MD - Blumenthal Cancer Center

• Opportunities Lost
  Otis W. Brawley, MD - American Cancer Society
   
• Drug Shortages in Breast Cancer
  Thomas Kornberg, PhD - UCSF Helen Diller Family Comprehensive Cancer Center

10:40 AM — 11:00 AM

Break

11:00 AM — 12:30 PM

General Session XI: Debates on Current Controversies in Systemic Therapy

Chairs: Gabriel N. Hortobagyi, MD – M. D. Anderson Cancer Center; Minetta C. Liu, MD – Georgetown University

• Use of Anthracyclines in HER2 Positive and HER2 Negative Patients
  Moderator: Gabriel N. Hortobagyi, MD – M. D. Anderson Cancer Center
  Pro: Clifford A. Hudis, MD – Memorial Sloan-Kettering Cancer Center
  Con: Stephen E. Jones, MD - US Oncology Research
   
• Bone Health/Role of Bisphosphonates in Early Stage Breast Cancer
  Moderator: Minetta C. Liu, MD - Georgetown University 
  Pro: Catherine Hall Van Poznak, MD – University of Michigan
  Con: Julie R. Gralow, MD – Seattle Cancer Care Alliance
  

12:30 PM

Adjourn

— Indicates Ticketed Session (information on registering for ticketed sessions)
* -- Indicates use of the Audience Response System (ARS)
^ -- Indicates use of the electronic question-and-answer (eQ&A) system